Klotho Neurosciences, Inc. 8-K Report: Key Financial Insights for Investors
Based on the provided section of the financial report for Klotho Neurosciences, Inc., here are the key extracted details and insights:
- Entity Identification:
- Company Name: Klotho Neurosciences, Inc.
- CIK Number: 0001907223
- SEC File Number: 001-41340
- EIN: 86-2727441
- Address: 13576 Walnut Street Suite A, Omaha, NE 68144
- Contact Number: 833-931-6330
- Report Type and Date:
- Form Type: 8-K (Current Report)
- Report Date: February 14, 2025
- Stock Information:
- Common Stock Identifier: KLTO (NASDAQ)
- Warrants Identifier: KLTOW (NASDAQ)
- Financial Period:
- Reporting Date: February 14, 2025
- The report includes specific contexts for common stock and warrants, suggesting the company is addressing both equity and derivative securities.
- Units of Measure:
- Financial measures are reported in USD (United States Dollar) and shares.
- The financial metrics presented may be related to the valuation of common stock and warrants, but specific monetary values are not included in the provided text.
- Insights:
- The report appears to be a current report (8-K), indicating that it is likely addressing significant events or changes that have occurred up to the reporting date.
- The presence of common stock and warrants suggests that the company may be engaging in activities that could affect its equity structure or capital raising efforts.
- The filing on February 14, 2025, indicates that this information is recent, which may be crucial for investors analyzing the company's current financial situation.
Overall, this section provides a snapshot of Klotho Neurosciences, Inc.'s current reporting status, identification details, and stock-related information, which can be vital for stakeholders looking to assess the company's market position and financial health.